Clinical trials
Leukemia, Promyelocytic, Acute trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 4 |
| Christian Medical College, Vellore, India | 2 |
| Peking University People's Hospital | 2 |
| The University of Hong Kong | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Associazione Italiana Ematologia Oncologia Pediatrica | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| First Affiliated Hospital of Harbin Medical University | 1 |
| German AML Cooperative Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Promyelocytic, Acute | 23 |
| Leukemia | 5 |
| Leukemia, Erythroblastic, Acute | 2 |
| Leukemia, Megakaryoblastic, Acute | 2 |
| Leukemia, Monocytic, Acute | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myelomonocytic, Acute | 2 |
| Recurrence | 2 |
| Congenital Abnormalities | 1 |
| Hemostatic Disorders | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.